Amelioration of intestinal and systemic sequelae of murine Campylobacter jejuni infection by probiotic VSL#3 treatment

被引:0
|
作者
Ira Ekmekciu
Ulrike Fiebiger
Kerstin Stingl
Stefan Bereswill
Markus M. Heimesaat
机构
[1] Charité-University Medicine Berlin,Department of Microbiology and Hygiene
[2] CC5,Department of Biological Safety
[3] Federal Institute for Risk Assessment (BfR),undefined
[4] National Reference Laboratory for Campylobacter,undefined
来源
关键词
Probiotic compound; VSL#3; Secondary abiotic mice; Gnotobiotic mice; Bacterial in vivo competition; Pathogen–commensal bacteria–host interaction; Apoptosis; Innate and adaptive immune cells; Pro-inflammatory cytokines; Anti-inflammatory cytokines; Extra-intestinal and systemic sequelae of infection;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 49 条
  • [21] Lactobacillus johnsonii ameliorates intestinal, extra-intestinal and systemic pro-inflammatory immune responses following murine Campylobacter jejuni infection
    Bereswill, Stefan
    Ekmekciu, Ira
    Escher, Ulrike
    Fiebiger, Ulrike
    Stingl, Kerstin
    Heimesaat, Markus M.
    SCIENTIFIC REPORTS, 2017, 7
  • [22] Change of Fecal Flora and Effectiveness of the Short-term VSL#3 Probiotic Treatment in Patients With Functional Constipation
    Kim, Seong-Eun
    Choi, Suck Chei
    Park, Kyung Sik
    Park, Moo In
    Shin, Jeong Eun
    Lee, Tae Hee
    Jung, Kee Wook
    Koo, Hoon Sup
    Myung, Seung-Jae
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 21 (01) : 111 - 120
  • [23] THE EFFECT OF SHORT TERM TREATMENT WITH PROBIOTIC VSL#3 ON VARIOUS CLINICAL AND BIOCHEMICAL PARAMETERS IN PATIENTS WITH LIVER CIRRHOSIS
    Marlicz, W.
    Wunsch, E.
    Mydlowska, M.
    Milkiewicz, M.
    Serwin, K.
    Mularczyk, M.
    Milkiewicz, P.
    Raszeja-Wyszomirska, J.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2016, 67 (06): : 867 - 877
  • [24] Probiotic VSL#3 Treatment Reduces Colonic Permeability and Abdominal Pain Symptoms in Patients With Irritable Bowel Syndrome
    Boonma, Prapaporn
    Shapiro, Jordan M.
    Hollister, Emily B.
    Badu, Shyam
    Wu, Qinglong
    Weidler, Erica M.
    Abraham, Bincy P.
    Devaraj, Sridevi
    Luna, Ruth Ann
    Versalovic, James
    Heitkemper, Margaret M.
    Savidge, Tor C.
    Shulman, Robert J.
    FRONTIERS IN PAIN RESEARCH, 2021, 2
  • [25] Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non-inferiority randomized controlled trial
    Mouli, Venigalla Pratap
    Benjamin, Jaya
    Singh, Mamta Bhushan
    Mani, Kalaivani
    Garg, Sushil Kumar
    Saraya, Anoop
    Joshi, Yogendra Kumar
    HEPATOLOGY RESEARCH, 2015, 45 (08) : 880 - 889
  • [26] Probiotic Bacteria VSL#3 Alter Visceral Sensitivity and Mucosa-Associated Intestinal Microbiota in Patients With Irritable Bowel Syndrome
    Ng, Siew C.
    Lam, Fung Chun
    Lam, Tommy Y.
    Chan, Yawen
    Law, Wai Tak W.
    Tse, C.
    Kamm, Michael A.
    Sung, Joseph J.
    Chan, Francis K. L.
    Wu, Justin C.
    GASTROENTEROLOGY, 2012, 142 (05) : S391 - S391
  • [27] Modulation of Intestinal Microbiota by the Probiotic VSL#3 Resets Brain Gene Expression and Ameliorates the Age-Related Deficit in LTP
    Distrutti, Eleonora
    O'Reilly, Julie-Ann
    McDonald, Claire
    Cipriani, Sabrina
    Renga, Barbara
    Lynch, Marina A.
    Fiorucci, Stefano
    PLOS ONE, 2014, 9 (09):
  • [28] Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis
    Mennigen, Rudolf
    Nolte, Kerstin
    Rijcken, Emile
    Utech, Markus
    Loeffler, Bettina
    Senninger, Norbert
    Bruewer, Matthias
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2009, 296 (05): : G1140 - G1149
  • [29] VARIABILITY IN INDUSTRIAL PRODUCTION AFFECTS PROBIOTICS ACTIVITY: IDENTIFICATION OF BATCHES OF PROBIOTIC VSL#3 THAT INCREASES INTESTINAL PERMEABILITY AND WORSENS COLITIS IN RODENTS
    Biagioli, Michele
    Cipriani, Sabrina
    Carino, Adriana
    Distrutti, Eleonora
    Marchiano, Silvia
    Fiorucci, Stefano
    GASTROENTEROLOGY, 2017, 152 (05) : S969 - S969
  • [30] Use of Vsl#3® (a new high concentration probiotic mixture) in the treatment of childhood diarrhea with specific reference to rotavirus diarrhea
    Dubey, Anand P.
    Krishnan, Rajeshwari
    Chakravarti, Anita
    Aggarwal, Arun
    Atal, Brij K.
    De Simone, Claudio
    Pandey, Vandana
    Sahu, Aditya R.
    GASTROENTEROLOGY, 2008, 134 (04) : A712 - A712